Everything outstanding, in the order it's worth doing. Drafts already written.
Nothing on this page changes a dose, and nothing on it is urgent. The schedule is settled and every total has been re-verified. Come back to this list when you have room.
ALCAR moved from 4:00 PM to 1:45 PM. It is now 6 AM (1 g) · 10 AM · 1:45 PM · 5 PM. Daily total unchanged at 2,500 mg. Everything else in the schedule is exactly where it was.
Do these first. Each one unblocks something else.
Open the Master Regimen note. 1:45 PM should list ALCAR 500 mg. 4:00 PM should not. The PDF you exported on 7/23 did not have the edit — either it saved after the export, or it didn't save. If it's missing, paste in the rev 7.25 file instead of re-editing by hand.
Highest value on this whole page. That doc is read first, every session — so a stale line there re-imports itself into every conversation forever. Two edits, one paste each.
• Dual-AI discipline — two operations, do not confuse them:
1. CORROBORATION — to test whether a finding replicates,
both models get the same original brief, independently,
neither seeing the other. Only then does agreement mean
anything.
2. AUDIT / SYNTHESIS — handing one model's output to the
other to stress-test its citations, find its errors, and
integrate it against my phenotype is a DIFFERENT operation
and is my primary workflow. It works. Do not discourage it.
The test: am I asking the second model to AGREE, or to WORK?
Agreement is worthless. Work is the point.
⟨the absolute "never cross-feed" form was Claude-origin,
overbroad, and is retired 7-23⟩
⚠️ Soy — protease-fraction concern, ACTIVITY-gated, not categorical. Kunitz/Bowman-Birk inhibit trypsin and chymotrypsin ONLY — not lipase, not amylase. Creon is dosed in USP lipase units, so the fraction the therapy is judged on is mechanically untouched. EXCLUDE raw/unheated/high-TIA soy (raw soy flour, raw soybeans, unheated soy protein powder). CLEARED: soy lecithin, soybean oil, fermented soy, hydrolysed soy protein/peptone, declared fermentation-medium traces. Yardstick: NaturDAO ~96 mg/day legume protein = cleared. Measure candidates against that, not against label presence. ⟨provenance unknown — demoted from ❌ at rev 7.21⟩
Two questions, then write down the lot number:
① Does it say "as ErinaPrime®"?
② Does it say "Contains: Milk, Soy"?
This settles the milk question by itself. ErinaPrime launched ~June 2026 — a pre-June bottle is different material, and any tolerance you built on it does not transfer. It also decides how much weight the ND email carries.
Both are genuinely open. Neither has a wrong answer that hurts you.
First, the thing that reframes it: the ~5 µg milk trace is inside the capsule. It is identical at 6 AM and at noon. Moving the slot does not reduce milk exposure at all — "no issues at 6 AM" records that the old bottle was tolerated, not that fasting protects. A3 settles that, not the clock.
⚠️ What outranks all three: the dose is unknown within 2× (label says 0.5%, Nammex publishes 1.0%), and 2.5 mg/day has no human anchor at all — the trials ran 5.25 and 10 mg/day. Optimising absorption of a possibly sub-anchor dose is second-order. If one thing gets done here, make it C1.
It is not single-variable, and the file said it was. HistaminX started 7/21 · Erinamax moved into Meal 1 on 7/22 — same meal, next day · agmatine changed slot 7/22 · ALCAR changed slot 7/23. Nothing needs undoing. This is bookkeeping.
⚠️ The specific collision to watch: Erinamax carries a declared milk trace, and the milk endpoint is the phlegm/cough response, which reads in days — the same timescale and system a probiotic readout uses.
Copy, paste, send. No composing required.
The highest-value message of the three. Question 4 is the one that matters: it decides whether you're taking 2.5 or 5 mg/day.
Subject: Erinamax — erinacine A assay and batch allergen data Hello, I take Erinamax daily and I'm trying to pin down two things the label leaves open. Four questions: 1. Batch allergen testing — what method, what LOD/LOQ, and what ppm threshold? "Non-detectable" against a 2.5 ppm assay and against a 20 ppm assay are different numbers, and I need to know which one I'm reading. 2. What form is the soy in the liquid-culture medium — intact protein, hydrolysate, or peptone? 3. What was the lot-transition date to ErinaPrime material? I want to know whether my bottle predates it. 4. Is the label's 0.5% erinacine A a guaranteed minimum or the actual assay value? Nammex publishes ErinaPrime at 1.0%, and your own wording is "at least 0.5%" — so my actual daily intake is either 2.5 mg or 5 mg and I can't tell which. If you have a COA for a recent lot, that would answer it directly. Thank you, Nathan Distelhorst
A records request, not a clinical question. Both may already exist; nobody has to order anything.
Two records questions from my 6/29–7/3 admission — I'm not asking for anything new to be ordered, just for what's already in the chart. 1. During the 6/29–7/3 enteroscopy, was gastric HISTOLOGY sent to pathology, or was H. pylori testing done by CLOtest / rapid urease only? If histology was sent, I'd like that result. 2. Could I have the PT / INR drawn during that same admission? Context for #2 if it's useful: I have EPI, which causes fat-soluble vitamin malabsorption including vitamin K, and I've never had vitamin K status checked. If PT was prolonged at the time of the bleed, that's worth knowing. Thank you, Nathan Distelhorst
This is a prescriber question, genuinely his. The blood-pressure case for stepping up has evaporated — he should see the numbers that made it evaporate.
I re-analysed my full blood pressure export — 59 readings, Jun 24 through Jul 22 — and the picture has changed enough that I think it changes the telmisartan question. Fasted morning, on 40 mg: Jul 4–8 136.6 / 66.9 (pulse pressure 69.7) Jul 9–22 120.8 / 66.5 (pulse pressure 54.3) That's -15.8 systolic and -15.4 pulse pressure with no antihypertensive change — and it happened despite Adderall going back to full dose on 7/13 and citrulline coming out on 7/10, both of which should have pushed the other way. My question: at a fasted morning of 120.8/66.5, is there any remaining indication for stepping to 80 mg? My understanding is that if a case remains it would be renal rather than hypertensive, which would turn on the UACR on the ~8/1 draw. One related item — both VM and Providence still have me listed at telmisartan 80 mg daily. Could that be corrected to 40 mg, along with the Adderall resumption to the full 70 mg/day? Thank you, Nathan Distelhorst
Two things. Nothing else needs your attention.
Sit 5 min · feet flat · back supported · bare arm at heart level · no talking. Three readings one minute apart. Discard #1. Average #2 and #3. Log to Apple Health.
Why it's on this list: 9 of the last 16 days had any morning session and only one had all three readings. Every gate in the file rests on this number, and it's the sparsest series you have. If you do one thing daily this week, do this.
Only ALCAR moved. Do not change anything else while you're away, including the two agmatine items flagged in the regimen — those are logged questions, not instructions. Adding a fourth change to the attribution window is the one thing that would actually cost you something.
None of this is time-sensitive before ~8/1.
Files are written and ready: the Perplexity brief and the stripped context file. This one is a corroboration pass — same prompt and context to both, independently, neither seeing the other. Then hand Claude both outputs and ask it to audit them against each other. That second step is your normal workflow and it's correct.
Why it matters: agmatine is 1,000 mg/day, it's the largest amine load in the stack, and no rationale for it has ever been written down in any revision. Re-derive it or retire it.
Requested 7/22–26. Ret-He (CHr) and TSAT are the ones that matter — ferritin alone will falsely reassure at 5 weeks post-op. This result is the only remaining measurement gate on R-ALA.
Settles melatonin 1 mg vs 3 mg. Costs nothing, may make the question moot.
Protein is named in the file as the single largest untouched lever — the post-surgical target is roughly 112–150 g/day and you've never measured against it. Amino-9 and HMB are not food. Fluid intake has never been quantified either, and it sits on the hyponatremia differential.
Draw list, telmisartan reassessment, and the standing-constraints provenance sweep — every ❌ and ⚠️ in that section, one at a time, asked "point at the source." The soy rule survived five adversarial revisions by looking settled; assume at least one more does.
Dark or tarry stool · visible blood · new dizziness · resting heart rate climbing · fever or rigors · any BP reading ≥180/120 → that's a call, not a message and not a wait.